Skip to Main Content

Paper Details

A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes.
Nat Commun
58
2021
Author NameAffiliation
Chao ShanWuhan Institute of Virology, Chinese Academy of Sciences
Zihe RaoNankai University
Zihe RaoCollege of Life Science, Nankai University
Zihe RaoFrontiers Science Center for Cell Responses, Nankai University
Zihe Rao
  • 1 - 5

Datasets

Release 1.2